Finance

Lists
Why is 301277 down 3,49%?
Dive Deeper
301277:SHE
Newland Pharmaceutical Co Ltd
9,69 CNY
-3,49%
(-0,35) 1D
19 ოქტ, 10:26:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301277...
Open
9,96 CNY
High
10,14 CNY
Low
9,64 CNY
Mkt. cap
3,94 მლრდ.
Avg. vol.
3,44 მლნ.
Volume
1,72 მლნ.
Dividend
2,06%
Quarterly dividend
0,05 CNY
Ex-dividend date
30 აპრ. 2026
P/E ratio
36,54
52-wk high
13,84 CNY
52-wk low
8,45 CNY
EPS
0,27 CNY
Shares outstanding
392,08 მლნ.
No. of employees
981
Open
9,96 CNY
High
10,14 CNY
Low
9,64 CNY
Mkt. cap
3,94 მლრდ.
Avg. vol.
3,44 მლნ.
Volume
1,72 მლნ.
Dividend
2,06%
Quarterly dividend
0,05 CNY
Ex-dividend date
30 აპრ. 2026
P/E ratio
36,54
52-wk high
13,84 CNY
52-wk low
8,45 CNY
EPS
0,27 CNY
Shares outstanding
392,08 მლნ.
No. of employees
981
News stories
From web sources and news partners
The Fintech Times
The Fintech Times
·
27 წუთის წინ
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Bloomberg.com
Bloomberg.com
·
4 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
About Newland Pharmaceutical Co Ltd
CEO-
Employees981
Founded15 სექ. 2005
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
122,43 მლნ.
191,14 მლნ.
206,95 მლნ.
190,03 მლნ.
Cost of goods sold
83,98 მლნ.
138,56 მლნ.
141,52 მლნ.
143,54 მლნ.
Cost of revenue
83,98 მლნ.
138,56 მლნ.
141,52 მლნ.
143,54 მლნ.
Research and development expenses
8,33 მლნ.
9,79 მლნ.
6,86 მლნ.
9,02 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13,48 მლნ.
16,44 მლნ.
14,66 მლნ.
13,83 მლნ.
Operating expense
22,06 მლნ.
29,05 მლნ.
23,97 მლნ.
25,68 მლნ.
Total operating expenses
106,04 მლნ.
167,61 მლნ.
165,49 მლნ.
169,23 მლნ.
Operating income
16,38 მლნ.
23,53 მლნ.
41,45 მლნ.
20,80 მლნ.
Other non operating income
2,67 მლნ.
-2,69 მლნ.
-123,00 ათ.
93,63 ათ.
EBT including unusual items
15,44 მლნ.
31,34 მლნ.
41,72 მლნ.
27,27 მლნ.
EBT excluding unusual items
21,71 მლნ.
22,93 მლნ.
42,86 მლნ.
23,81 მლნ.
Income tax expense
2,11 მლნ.
2,54 მლნ.
5,95 მლნ.
2,96 მლნ.
Effective tax rate
13,69%
8,12%
14,25%
10,84%
Other operating expenses
1,33 მლნ.
531,26 ათ.
1,86 მლნ.
1,22 მლნ.
Net income
13,87 მლნ.
29,35 მლნ.
36,10 მლნ.
24,67 მლნ.
Net profit margin
11,33%
15,35%
17,44%
12,98%
Earnings per share
-
-
-
-
Interest and investment income
2,70 მლნ.
2,18 მლნ.
1,57 მლნ.
3,05 მლნ.
Interest expense
-51,38 ათ.
-48,10 ათ.
-34,88 ათ.
-23,86 ათ.
Net interest expenses
2,65 მლნ.
2,13 მლნ.
1,53 მლნ.
3,03 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
25,16 მლნ.
36,67 მლნ.
54,59 მლნ.
37,12 მლნ.
Gain or loss from assets sale
-466,62 ათ.
-
-
-235,40 ათ.
AI content may include mistakes. Learn more
Google აპები